FDA: Out-Of-Spec Components May Be Used In Finished Devices - But Beware
This article was originally published in The Silver Sheet
DEVICE FIRMS FREQUENTLY ADJUST MANUFACTURING PROCESSES to accommodate components that are out of specification, but that isn't necessarily a problem as long as the product meets "finished device specifications and all of its labeling requirements," FDA quality system expert Jan Welch says. During an agency inspection, FDA will check to see whether a firm's manufacturing change is a one-time exception or if the company makes changes on a regular basis. "The occasional one-off situation for a component or material may be acceptable with justification," Welch says. A company will typically consider the type of component, its risk of possible failure and whether it's critical to the proper functioning of the device when deciding whether to use out-of-specification components. Experts at device manufacturers Medrad, Nonin Medical and Enzymatics tell how they handle incoming material
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.